Streptococcus agalactiae DNA [Presence] in Vag+Rectum by NAA with probe detection

Gp B Strep DNA Vag+Rectum Ql NAA+probe

Definition

The CDC recommends universal screening for Group B Streptococcus using a single swab from the lower vagina and rectum at 35-37 weeks' gestation in order to prevent perinatal group B streptococcal disease. [http://www.acog.org/Resources_And_Publications/Committee_Opinions/Committee_on_Obstetric_Practice/Prevention_of_Early-Onset_Group_B_Streptococcal_Disease_in_Newborns]

3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; Deoxyribonucleic acid; DNA NUCLEIC ACID PROBE; DNA probe; GBS; Genital vaginal; Gp B Strep; Group B; Group B Strep; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Ordinal; PCR; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; QBR; QL; Qual; Qualitative; Random; Rectal; S agalactiae; Screen; SDA; Steptococcus Group B; Strand Displacement Amplification; Strep; Strep B; Strep group B; Strept; Streptococci group B; TMA; Transcription mediated amplification; Vag fld; Vag fluid; Vagina; Vaginal fluid

12 further terms